Heinz Mäusli

Mr. Heinz Mäusli is a director and a member of the Audit Committee and Compensation Committee, serving on the Board of Directors since June 2020. He is also a member of the board of Inventiva SA.  He served on the board of directors of Progenics Pharmaceuticals, Inc. until its acquisition by the Company.  Mr. Mäusli is the former Chief Financial Officer of Advanced Accelerator Applications S.A., previously serving on its board and also on the executive team that managed its integration into Novartis AG after helping it grow into a global leader within its field. Mr. Mäusli previously worked as a management consultant for a number of strategy projects in both Europe and the United States for Accenture and Gemini Consulting, as well as independently. He brings more than 15 years of experience in the molecular nuclear medicine industry, as well as significant management and executive experience.